1. Home
  2. SKIL vs ACET Comparison

SKIL vs ACET Comparison

Compare SKIL & ACET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Skillsoft Corp.

SKIL

Skillsoft Corp.

HOLD

Current Price

$3.71

Market Cap

32.5M

Sector

Technology

ML Signal

HOLD

Logo Adicet Bio Inc.

ACET

Adicet Bio Inc.

HOLD

Current Price

$7.21

Market Cap

69.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SKIL
ACET
Founded
1998
1947
Country
United States
United States
Employees
2261
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.5M
69.6M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
SKIL
ACET
Price
$3.71
$7.21
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$65.33
AVG Volume (30 Days)
148.0K
130.1K
Earning Date
01-01-0001
06-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.72
$0.45
52 Week High
$23.00
$9.05

Technical Indicators

Market Signals
Indicator
SKIL
ACET
Relative Strength Index (RSI) 31.34 50.32
Support Level $3.72 $6.54
Resistance Level $4.84 $8.46
Average True Range (ATR) 0.47 0.48
MACD 0.08 -0.05
Stochastic Oscillator 0.45 37.93

Price Performance

Historical Comparison
SKIL
ACET

About SKIL Skillsoft Corp.

Skillsoft Corp is a leader in corporate digital learning. The company's segments include Talent Development Solutions and Global Knowledge. Talent Development Solutions brings a foundation of products and customers. TDS enterprise-grade solution serves customers and employees world-wide. TDS Learner is a world-renowned consumer-scale and experiential learning platform that serves learners internationally. The Global Knowledge segment is centered around instructor-led training, or live learning, with face-to-face delivery by experienced trainers, both in-person and virtually.

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.

Share on Social Networks: